Communiqués Amphastar Pharmaceuticals, Inc.

Actions

AMPH

US03209R1032

Produits pharmaceutiques

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 24/07/2026			Varia. 5j.	Varia. 1 janv.
18,72 ^USD	-0,79%		-5,19%	-30,10%

13/07	Amphastar Pharmaceuticals, Inc. annonce des changements au sein de son conseil d'administration, effectifs au 9 juillet 2026	CI
08/07	Une filiale d'Amphastar reçoit une lettre d'avertissement de la FDA concernant des violations dans une usine en Californie	MT

Communiqués

27/05	Amphastar Pharmaceuticals to Present at the 2026 Jefferies Healthcare Conference	AQ
12/05	Amphastar Pharmaceuticals : 2026 Bank of America Health Care Conference	PU
08/05	Amphastar Pharmaceuticals : Q1 Financial Results (news)	PU
08/05	Amphastar Pharmaceuticals : Quarterly Report for Quarter Ending 2026-03-31 (Form 10-Q)	PU
08/05	Amphastar Pharmaceuticals : Q1 2026 Earnings Presentation	PU
07/05	Amphastar: Q1 Earnings Snapshot	AQ
07/05	Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2026	AQ
06/05	Amphastar Pharmaceuticals to Present at the 2026 Bank of America Health Care Conference	AQ
30/04	Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7, 2026	AQ
14/04	Amphastar Pharmaceuticals : 25th Annual Needham Virtual Healthcare Conference	PU
06/04	Amphastar Pharmaceuticals to Present at the 25th Annual Needham Healthcare Conference	AQ
10/03	Amphastar Pharmaceuticals : Barclays 28th Annual Global Healthcare Conference Presentation	PU
26/02	Amphastar Pharmaceuticals : Reports Financial Results for the Three Months and Full Year Ended December 31, 2025	PU
26/02	Amphastar: Q4 Earnings Snapshot	AQ
12/01	Amphastar Pharmaceuticals : Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthetic Corticotropin Compound	PU
20/11	Amphastar Pharmaceuticals : Q2 Financial Results (AMP 2025 Q2 Earnings Release FINAL)	PU
20/11	Amphastar Pharmaceuticals : Q1 Financial Results (AMP 2025 Q1 Earnings Release FINAL)	PU
20/11	Amphastar Pharmaceuticals : Q3 Financial Results (AMP 2025 Q3 Earnings Release FINAL)	PU
18/11	Amphastar Pharmaceuticals : Jefferies 2025 London Healthcare Presentation	PU
06/11	Amphastar Pharmaceuticals : Reports Financial Results for the Three Months Ended September 30, 2025	PU
06/11	Amphastar: Q3 Earnings Snapshot	AQ
03/09/25	Amphastar Pharmaceuticals : Wells Fargo Healthcare Presentation	PU
12/08/25	Amphastar Announces FDA Approval for Iron Sucrose Injection, USP	AQ
07/08/25	Amphastar Pharmaceuticals : Q2 Financial Results (news)	PU
07/08/25	Amphastar: Q2 Earnings Snapshot	AQ